Kenvue faces challenges with declining sales, cash flow risks, and high leverage. Read here for more analysis on KVUE stock.

Aid, Listerine, Neutrogena, and Johnson's consumer products, reported disappointing Q2 sales and just announced that its CEO ...

Kenvue Inc. (NYSE:KVUE) is included among the 11 Best Halal Dividend Stocks to Buy Now. In August 2023, Johnson & Johnson ...

This was the stock's third consecutive day of gains.

Kenvue, a consumer health company and makers of Benadryl cough syrup, on Friday announced the launch of 'Cough Clinics', an ...

With the duration and frequency of cough episodes increasing among Indians since the onset of COVID-19, Kenvue, the world’s ...

Kenvue Inc. (NYSE: KVUE) is one of the stocks on Jim Cramer’s radar. During the episode, Cramer discussed the company’s ...

Kenvue and API launch India's first Cough Clinics to improve cough diagnosis and treatment. The initiative aims to address ...

Benadryl maker Kenvue partners with the Association of Physicians of India to open Centres of Excellence for clinical ...

Our Bureau, Mumbai Monday, July 21, 2025, 17:15 Hrs [IST] ...

Eric Brophy will join CSG Law to co-chair a new government and regulatory law group after serving in Gov. Murphy’s administration.

The consumer health company also disclosed its CEO’s departure, following its CFO replacement earlier this year, and appointed an interim chief executive. Preliminary second-quarter 2025 results show ...